Azithromycin 600 mg bioequivalence study


Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg [Completed] Comparative Bioavailability Study of 600mg Azithromycin Monohydrate. Aim: To compare the bioavailability of two Azithromycin tablet formulations 500 mg Azivol� tablets as test formulation and 500 mg Zithromax� tablets as. Clinical Trials - The purpose of this study is to demonstrate the bioequivalence of Azithromycin Monohydrate 600 mg Tablets. Type of study: Fasting Bioequivalence based on (90% CI): Azithromycin studies on the 600 mg strength, (ii) proportionally similar across all strengths, and.

NCT00830206, A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral NCT00649935, Fed Study of Azithromycin Tablets 600 mg to Zithromax.